Mosquito Repellents: A Guide to the Availability and Effectiveness of Commercial Formulations in Argentina

Abstract

Purpose of Review: This review aims to effectively highlight the essential characteristics of commercially approved repellent active ingredients while exploring their known mechanisms of action. Understanding these factors is crucial for developing more effective repellents in the future.Recent Findings: Several commercial products have been developed to protect individuals from mosquito bites. In Argentina, over 75% of the products registered by the National Administration of Drugs, Food, and Medical Technology (ANMAT) are based on DEET, while 12% use IR3535. ANMAT regulates these products, ensuring their quality and safety for human use.Summary: The mosquito Aedes aegypti (L.) transmit of Zika, yellow fever, chikungunya, and dengue. Due to their obligate hematophagy, they pose a significant threat to public health. They exhibit great adaptability to multiple environments across varying latitudes and altitudes and show a strong preference for humans. Insect repellents provide critical topical personal protection against infectious diseases transmitted by arthropods. This work provides essential insights for selecting the ideal repellents. By focusing on their mode of action, origin, effectiveness, and ANMAT approval status, you’ll be empowered to make informed decisions for optimal protection.